ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $492,364 (100.0% shares, 0.0% debt)

Holdings (9)

RAPP RAPPORT THERAPEUTICS INC. 22.5%

Value ($000) $110,744 Shares 3,728,738 Est. Cost $23.15 Unrealized -23.0%

BEAM BEAM THERAPEUTICS INC. 22.4%

Value ($000) $110,189 Shares 4,540,132 Est. Cost $24.56 Unrealized -19.0%

MAZE MAZE THERAPEUTICS INC. 21.7%

Value ($000) $106,833 Shares 4,120,053 Est. Cost $12.04 Unrealized +40.2%

VIR VIR BIOTECHNOLOGY INC. 15.0%

Value ($000) $73,754 Shares 12,916,663 Est. Cost $5.36 Unrealized -4.6%

LYEL LYELL IMMUNOPHARMA INC. 9.1%

Value ($000) $44,807 Shares 2,759,072 Est. Cost $9.90 Unrealized +15.4%

ERAS ERASCA INC. 4.9%

Value ($000) $24,101 Shares 11,055,554 Est. Cost $17.12 Unrealized -90.7%

GOSS GOSSAMER BIO INC. 4.3%

Value ($000) $21,187 Shares 8,055,916 Est. Cost $1.15 Unrealized +91.3%

QTTB Q32 BIO INC. 0.1%

Value ($000) $635 Shares 320,482 Est. Cost $13.78 Unrealized -86.1%

CERO CERO THERAPEUTICS HOLDINGS INC. 0.0%

Value ($000) $114 Shares 22,389 Est. Cost $12.44 Unrealized -40.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RAPP	RAPPORT THERAPEUTICS INC.	3,728,738	$110,744	22.5%	$23.15	-23.0%	COM	75383L102
BEAM	BEAM THERAPEUTICS INC.	4,540,132	$110,189	22.4%	$24.56	-19.0%	COM	07373V105
MAZE	MAZE THERAPEUTICS INC.	4,120,053	$106,833	21.7%	$12.04	+40.2%	COM	578784100
VIR	VIR BIOTECHNOLOGY INC.	12,916,663	$73,754	15.0%	$5.36	-4.6%	COM	92764N102
LYEL	LYELL IMMUNOPHARMA INC.	2,759,072	$44,807	9.1%	$9.90	+15.4%	COM NEW	55083R203
ERAS	ERASCA INC.	11,055,554	$24,101	4.9%	$17.12	-90.7%	COM	29479A108
GOSS	GOSSAMER BIO INC.	8,055,916	$21,187	4.3%	$1.15	+91.3%	COM	38341P102
QTTB	Q32 BIO INC.	320,482	$635	0.1%	$13.78	-86.1%	COM	746964105
CERO	CERO THERAPEUTICS HOLDINGS INC.	22,389	$114	0.0%	$12.44	-40.9%	COM	71902K402